Table 1.
Haemophilus influenzae Type b Vaccines
| Vaccine | Brand Name | Manufacturer | Carrier Protein |
|---|---|---|---|
| Monovalent | |||
| PRP | B-CAPSA 1 | Praxis | None |
| HibImmune | Lederle | None | |
| HibVAX | Connaught | None | |
| PRP-D | ProHIBiT | Connaught | Diphtheria toxoid |
| HbOC | HibTITER | Praxis | CRM197 |
| PRP-OMP | PedvaxHIBa | Merck & Co, Inc | Neisseria meningitidis outer membrane protein |
| PRP-T | ActHIBa | Sanofi Pasteur | Tetanus toxoid |
| OmniHIB | Sanofi Pasteur | Tetanus toxoid | |
| Hiberixa | GlaxoSmithKline | Tetanus toxoid | |
| Combination | |||
| PRP-T, DTaP | Actacel | Sanofi | |
| HbOC, DTP | Tetrammune | Lederle | |
| PRP-OMP, HepB | Comvax | Merck & Co, Inc | |
| PRP-T, DTaP, IPV | Pentacela | Sanofi Pasteur | |
| PRP-T, MenAY | MenHibrix | GlaxoSmithKline | |
| PRP-OMP, DTaP, IPV, HepB | Vaxelisb | Sanofi Pasteur & Merck & Co, Inc |
Abbreviations: DTaP, diphtheria, tetanus, acellular pertussis; DTP, diphtheria, tetanus, pertussis; HbOC, Haemophilus b oligosaccharide conjugate; HepB, hepatitis B; IPV, inactivated polio vaccine; MenAY, meningococcal types A and Y; PRP, polyribosylribitol phosphate; PRP-D, polyribosylribitol phosphate-diphtherai; PRP-OMP, polyribosylribitol phosphate-outer membrane protein; PRP-T, polyribosylribitol phosphate-tetanus toxoid.
aCurrently available in the United States.
bAvailable 2020–2021 in the United States.